New study tests simple behavioral tricks to keep opioid patients in treatment

NCT ID NCT07607743

Not yet recruiting Disease control Sponsor: Boston University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two behavioral interventions—Behavioral Activation (finding enjoyable activities) and Attendance Reinforcement (vouchers for showing up)—to help people with opioid use disorder stay on buprenorphine treatment for at least 6 months. Researchers will enroll 240 adults who recently started buprenorphine or were recently released from jail. The goal is to find the best combination of these low-cost, remote-delivered supports to improve treatment retention and reduce overdose risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Behavioral interventions (Behavioral Activation and Attendance Reinforcement)
What this could lead to: If successful, this could provide a practical, low-cost way to help more people stick with opioid addiction treatment, reducing overdose risk and improving long-term recovery.
What could go wrong: This is an early-stage optimization trial, not a test of a new drug. The behavioral interventions may not significantly improve retention, and results may not apply to all treatment settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPIOID-USE DISORDER

More trials for these conditions

Other studies related to the condition(s) this trial covers.